Design and analysis of randomized clinical trials for onchocerciasis, loiasis and mansonellosis: A systematic review

by Lotola Mougeni F, Bofill Roig M, Hübner MP, Klarmann-Schulz U, Lenz B, Specht S, Posch M, Zehetmayer S. PLOS Neglected Tropical Diseases 2026, 20(2): e0013992. doi:10.1371/journal.pntd.0013992

Summary: Filarial diseases such as onchocerciasis, loiasis, and mansonellosis affect millions of people. However, conducting and analyzing trials of potential treatments can be difficult because patient numbers are often small and the measurements used to evaluate treatment success can vary widely. The authors of this study systematically reviewed randomized clinical trials from the past 25 years, examining the design, analysis of the results, and statistical methods applied. Although many were well planned, there was substantial variation including in primary outcome measures, duration of follow-up, and data analysis methods. In several trials, essential details were insufficiently reported, limiting comparisons across studies. Clearer, more consistent reporting and the use of advanced statistical methods would make such trials more reliable and easier to interpret.

Access article

The post Design and analysis of randomized clinical trials for onchocerciasis, loiasis and mansonellosis: A systematic review first appeared on DNDi.

Ayuda a los pacientes desatendidos

Hasta la fecha, hemos desarrollado nueve tratamientos para enfermedades desatendidas, salvando millones de vidas. Nuestro objetivo es poner a disposición 25 nuevos tratamientos en nuestros primeros 25 años. ¡Nos puedes ayudar!

Organización internacional sin fines de lucro que desarrolla tratamientos seguros, efectivos y asequibles para los pacientes más desatendidos.

DNDi Global

Contáctenos

DNDi en el mundo

Apoye la DNDi

¡Haga una donación!

Trabaje con nosotros

Oportunidads

A excepción de imágenes, películas y marcas comerciales que están sujetas a los Términos de uso de la DNDi, el contenido de este sitio tiene una licencia Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license.